Michael R. Doschak, Ph.D.
Affiliations: | 2004 | University of Calgary, Calgary, Alberta, Canada |
Area:
Medicine and Surgery, PharmacologyGoogle:
"Michael Doschak"Parents
Sign in to add mentor| Ronald Zernicke | grad student | 2004 | University of Calgary | |
| (Bisphosphonate antiresorptive drug use in a rabbit model of osteoarthritis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Paparella I, LeBlanc ARH, Doschak MR, et al. (2020) The iliosacral joint in lizards: an osteological and histological analysis. Journal of Anatomy |
| J Hill M, Qi B, Bayaniahangar R, et al. (2019) Nanomaterials for bone tissue regeneration: updates and future perspectives. Nanomedicine (London, England) |
| Tang KC, Pan W, Doschak MR, et al. (2019) Increased FoxO3a expression prevents osteoblast differentiation and matrix calcification. Bone Reports. 10: 100206 |
| Wei Y, Elahy M, Friedhuber AM, et al. (2019) Triple-threat activity of PEDF in bone tumors: Tumor inhibition, tissue preservation and cardioprotection against doxorubicin. Bone |
| Yang Y, Aghazadeh-Habashi A, Panahifar A, et al. (2017) Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats. Drug Delivery and Translational Research |
| Kwon S, Wang A, Sadowski C, et al. (2017) Urinary Bone Turnover Markers as Target Indicators for Monitoring Bisphosphonate Drug Treatment in the Management of Osteoporosis. Current Drug Targets |
| Xing JZ, Lu L, Unsworth LD, et al. (2016) RANKL Release from Self-assembling Nanofiber Hydrogels for Inducing Osteoclastogenesis In-Vitro. Acta Biomaterialia |
| Yang Y, Pushie MJ, Cooper DM, et al. (2015) Structural Characterization of SmIII(EDTMP). Molecular Pharmaceutics |
| Elahy M, Doschak MR, Hughes JD, et al. (2015) Alginate bead-encapsulated PEDF induces ectopic bone formation in vivo in the absence of co-administered mesenchymal stem cells. Current Drug Targets |
| Yang Y, Richter S, Wuest F, et al. (2015) Synthesis and structural identification of fluorine-18 labeled parathyroid hormone. Journal of Labelled Compounds & Radiopharmaceuticals. 58: 453-7 |